Summary
(1)We have studied the ability of some regulatory peptides to induce a mitogenic (incorporation of tritiated thymidine) response in human peripheral blood mononuclear cells (PBMC) and to modify the response produced by phytohaemagglutinin (PHA), a well known PBMC mitogen. (2) Human calcitonin gene-related peptide (hCGRP), human or salmon calcitonin (hCT, sCT), neurokinin A (NKA) and neurokinin (4–10) (up to 1 μM for each peptide) did not produce per se any significant PBMC stimulation. (3) hCGRP (0.1 nM −1 μM) produced a concentration dependent enhancement of the response to a submaximal concentration of PHA (1 μg/ml). On the other hand, hCGRP decreased the mitogenic response to a maximal concentration of PHA (25 μg/ml). (4) Neither hCT nor sCT (0.1 nM−1 μM) had a significant influence on the response to PHA (1–25 μg/ml). (5) Both NKA and NKA (4–10) produced a concentration-dependent (1 fM −10 pM) enhancement of the response to 1 μg/ml PHA, while these compounds had no effect on the response to 25 μg/ml PHA. (6) These findings suggest a potent modulatory action of CGRP and NKA, two peptides present in sensory and other nerves, on immune function which is possibly mediated via C2 receptors for CGRP and NK-2 tachykinin receptors, respectively.
Similar content being viewed by others
References
Amara SG, Arriza JL, Leff SE, Swanson LW, Evans RM, Rosenfeld MG (1985) Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide. Science 229: 1094–1097
Bhathena SJ, Louie J, Scheeler GP, Redman RS, Wahl L, Recant L (1981) Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes 30: 127–133
Blalock JB (1984) The immune system as a sensory organ. J Immunol 132: 1067–1070
Boyum A (1968) Separations of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 21: (Suppl 97) 77–89
Casini A, Alberti A, Banchetti E, Schiavon E, Patussi V, Pontisso P, Surrenti C, Realdi G (1987) Cell-mediated immunity to HBcAg in chronic HBV infection. Am J Clin Pathol 88: 494–498
Diez-Guerra FJ, Zaidi M, Bevis P, McIntyre I, Emson PC (1988) Evidence for release of calcitonin gene-related peptide and neurokinin A from sensory nerve endings in vivo. Neuroscience 25: 839–846
Fink T, Weihe E (1988) Multiple neuropeptides in nerves supplying mammalian lymph nodes: messenger candidates for sensory and autonomic neuroimmunomodulation. Neurosci Lett 90: 39–44
Geppetti P, Maggi CA, Zechi-Orlandini S, Santicioli P, Meli A, Frilli S, Spillantini MG, Amenta F (1987) Substance P-like immunoreactivity in capsaicin-sensitive structures of the rat thymus. Regul Peptid 18: 321–327
Geppetti P, Theodorsson-Norheim E, Ballerini G, Alessandri M, Maggi CA, Santicioli P, Amenta F, Fanciullaci M (1988) Capsaicin-sensitive tachykinin-like immunoreactivity in the thymus of rats and guinea-pigs. J Neuroimmunol 19: 3–9
Gibbins IL, Furness JB, Costa M, McIntyre I, Hillyard CJ, Girgis S (1985) Co-localization of CGRP-like immunoreactivity with substance P in cutaneous vascular and visceral sensory neurons of guinea-pigs. Neurosci Lett 57: 125–130
Giuliani S, Maggi CA, Rovero P, Meli (1988) Neurokinins induce a relaxation of rat duodenum in vivo by activating postganglionic sympathetic elements in prevertebral ganglia — Involvement of an NK-2 type of neurokinin receptor. J Pharmacol Exp Ther 246: 322–328
Go VLW, Yaksh TL (1987) Release of Substance P from the cat spinal cord. J Physiol (Lond) 391: 141–167
Helme RD, Ezlegos A, Hosking CS (1987a) Substance P induces chemotaxis of neutrophils in normal and capsaicin-treated rats. Immunol Cell Biol 65: 267–269
Helme RD, Eglezos A, Dandie GW, Andrews PV, Boyd RL (1987b) The effect of substance P on the regional lymphonode antibody response to antigenic stimulation in capsaicin-pretreated rats. J Immunol 139: 3470–3473
Hokfelt T, Kellerth JO, Nilsson G, Pernow B (1975) Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res 100: 235–252
Hokfelt T, Elde R, Johansson O, Luft R, Nilsson G, Arimura A (1976) Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurones. Neuroscience 1: 131–136
Holzer P (1988) Local effector function of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, CGRP and other neuropeptides. Neuroscience 24: 739–768
Hua XY, Saria A, Gamse R, Theodorsson-Norheim E, Brodin E, Lundberg JM (1986) Capsaicin induced release of multiple tachykinins (substance P, neurokinin A and eledoisin-like material) from guinea-pig spinal cord and ureter. Neuroscience 19: 313–319
Kuraishi Y, Hirota N, Sato Y, Kaneko S, Satoh M, Takagi H (1985) Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res 325: 294–298
Lembeck F (1953) Zur Frage der zentralen Übertragung afferenter Impulse. III. Mitteilung. Das Vorkommen und die Bedeutung der Substanz P in den dorsalen Wurzeln des Rückenmarks. Arch Exp Path Pharmacol 219: 197–213
Lembeck F (1988) The Ulf Von Euler Lecture — Substance P from extract to excitement. Acta Physiol Scand 133: 435–454
Lembeck F, Holzer P (1979) Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 310: 175–183
Lundberg JM, Franco-Cereceda A, Hua XY, Hokfelt T, Fischer J (1985) Co-existence of substance P and CGRP immuno-reactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 108: 315–319
Maggi CA, Meli A (1988) The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen Pharmacol 19: 1–43
Maggi CA, Parlani M, Astolfi M, Santicioli P, Rovero P, Abelli L, Somma V, Giuliani S, Regoli D, Meli A (1988) Neurokinin receptors in the lower urinary tract. J Pharmacol Exp Ther 246: 308–315
Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Passaro EP, Vigna SR, Maggio JE, Kruger L, Mantyh PW (1988) Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci 85:3235–3239
Martling CR, Theodorsson-Norheim E, Norheim I, Lundberg JM (1987) Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig — evidence for extraneuronal cleavage of neuropeptide K to neurokinin A. Naunyn-Schmiedeberg's Arch Pharmacol 336:183–189
McGillis JP, Organist ML, Payan DG (1987) Substance P and immunoregulation. Fed Proc 46:196–199
Morley JE, Kay NE, Solomon GF, Plotnikoff NP (1987) Neuropeptides: conductors of the immune orchestra. Life Sci 41:527–544
Norheim I (1986) Carcinoid tumors: clinical studies and the use of tachykinins as tumor markers. Acta Universitatis Upsaliensis, Uppsala Sweden, 40, pp 1–57
O'Dorisio MS, Wood DL, O'Dorisio TM (1985) Vasoactive intestinal peptide and neuropeptide modulation of the immune response. J Immunol 135:792–796
Otsuka M, Konishi S, Yanagisawa M, Tsunoo A, Akagi H (1982) Role of substance P as a sensory transmitter. In: Porter R, O'Connor M (eds) Spinal cord and ganglia in Substance P and the Nervous System. Pittman, London, pp 13–30
Payan DG, Brewster DR, Goetzl EJ (1983) Specific stimulation of human T lymphocytes by substance P. J Immunol 131:1613–1615
Payan DG, Brewster DR, Missirian-Bastan A, Goetzl EJ (1984) Substance P recognition bu a subset of human T lymphocytes. J Clin Invest 74:1532–1539
Payan DG, Goetzl EJ (1985) Modulation of lymphocyte function by sensory neuropeptides. J Immunol 135:783–786
Popper P, Mantyh CR, Vigna SR, Maggio JE, Mantyh PW (1988) The localization of sensory nerve fibers and receptor binding sites for sensory neuropeptides in canine mesenteric lymph nodes. Peptides 9:257–267
Regoli D, Drapeau G, Dion S, D'Orleans-Juste P (1986) Receptors for neurokinins in peripheral organs. In: Henry JI, Couture R, Cuello AC, Pelletier G, Quirion R, Regoli D (eds) Substance P and neurokinins. Springer, Berlin Heidelberg New York Tokyo, pp 99–107
Regoli D, Drapeau G, Dion S, D'Orleans-Juste P (1987) Pharmacological receptors for substance P and neurokinins. Life Sci 40:109–118
Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processing. Nature 304:129–135
Saria A, Gamse R, Petermann J, Fischer JA, Theodorsson-Norheim E, Lundberg JM (1986) Simultaneous release of several tachykinins and CGRP from rat spinal cord slices. Neurosci Lett 63:310–314
Scicchitano R, Biennenstock J, Stanisz AM (1988) In vivo immunomodulation by the neuropeptide substance P. Immunology 63:733–735
Sexton PM, McKenzie JS, Mendelsohn FAO (1988) Evidence for a new subclass of calcitonin/calcitonin gene related peptide binding sites in rat brain. Neurochem Internat 12:323–335
Souquet JC, Grider JR, Britar KN, Makhlouf GM (1985) Receptors for mammalian tachykinins on isolated intestinal smooth muscle cells. Am J Physiol 249:G533-G538
Theodorsson-Norheim E, Joernvall H, Anderssonn M, Norheim I, Oberg K, Jacobsson G (1987) Isolation and characterization of neurokinin A, neurokinin (3—10) and neurokinin (4—10) from a neutral water extract of a metastatic ileal carcinoid tumor. Eur J Biochem 166:693–698
Wagner F, Fink R, Hart R, Dancyger H (1987) Substance P enhances interferon-gamma production by human peripheral blood mononuclear cells. Regul Peptides 19:355–364
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Casini, A., Geppetti, P., Maggi, C.A. et al. Effects of calcitonin gene-related peptide (CGRP), neurokinin A and neurokinin A (4–10) on the mitogenic response of human peripheral blood mononuclear cells. Naunyn-Schmiedeberg's Arch Pharmacol 339, 354–358 (1989). https://doi.org/10.1007/BF00173591
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173591